Changes in haematological variables with one-year treatment with pioglitazone, metformin and gliclazide in 3713 type 2 diabetic patients

被引：0
|
作者：
Belcher, G
Edwards, G
Urquhart, R
Eckland, D
Tan, M
Herz, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [1] Results of liver safety testing in 3713 type 2 diabetic patients treated for one year in double blind controlled trials with pioglitazone, metformin or gliclazide
    Blecher, G
    Lambert, C
    Edwards, G
    Tan, MG
    Herz, M
    DIABETES, 2003, 52 : A112 - A112
  • [2] Results of liver safety testing in 3713 Type 2 diabetic patients treated for one year in double blind controlled trials with pioglitazone, metformin or gliclazide.
    Belcher, G
    Lambert, C
    Edwards, GC
    Tan, MH
    Herz, M
    DIABETOLOGIA, 2003, 46 : A291 - A291
  • [3] Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide
    Belcher, G
    Schernthaner, G
    DIABETIC MEDICINE, 2005, 22 (08) : 973 - 979
  • [4] Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide
    Belcher, G
    Lambert, C
    Goh, KL
    Edwards, G
    Valbuena, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (09) : 833 - 837
  • [5] Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes
    Belcher, G
    Lambert, C
    Edwards, G
    Urquhart, R
    Matthews, DR
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (01) : 53 - 62
  • [6] One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
    Hanefeld, M
    Brunetti, P
    Schernthaner, GH
    Matthews, DR
    Charbonnel, BH
    DIABETES CARE, 2004, 27 (01) : 141 - 147
  • [7] Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes
    Al-Azzam, Sayer I.
    AlOmari, Mousa
    Khader, Yousef S.
    AlMahasneh, Fatimah A.
    Muflih, Suhaib M.
    Altawalbeh, Shoroq
    ENDOCRINE RESEARCH, 2012, 37 (01) : 7 - 11
  • [8] Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients
    Derosa, G.
    Maffioli, P.
    Ferrari, I.
    Mereu, R.
    Ragonesi, P. D.
    Querci, F.
    Franzetti, I. G.
    Gadaleta, G.
    Ciccarelli, L.
    Piccinni, M. N.
    D'Angelo, A.
    Salvadeo, S. A. T.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (09) : 663 - 669
  • [9] Weight changes with treatment of type 2 diabetes with pioglitazone, metformin and gficlazide
    Belcher, G
    Edwards, G
    Urquhart, R
    Eckland, D
    Johns, D
    Tan, MG
    DIABETES, 2003, 52 : A111 - A111
  • [10] One-Year Experience Using Liraglutide in Hospitalized Type 2 Diabetic Patients
    Girbes-Borras, Juan
    Minguez-Verdejo, Ramona
    Sales-Sanz, Jorge
    Inigo-Zaera, Pilar
    Fernandez-Navarro, Jose Ignacio
    Catalabauset, Miguel
    DIABETES, 2015, 64 : A652 - A652
12345